AATOD 2006 Conference Registration Brochure

Working with Criminal Justice and Health Care Systems
American Association for the Treatment of Opioid Dependence
Tuesday, April 25, 2006
TIME: 7:00 PM – 9:30 PM
AWARDS BANQUET
Please join us for the centerpiece of our Conference, a moving tribute to those individuals who have been nominated and selected by
their peers for extraordinary service in the opioid treatment field. In 1983, Dr. Vincent Dole and Dr. Marie Nyswander were the first
recipients of this Award. The Association continues to bestow this honor to individuals who have devoted themselves to improving the
lives of patients in our treatment system.
The Nyswander / Dole Award: “Marie Award” will be presented by Jerome Jaffe, MD
Dr. Jerome Jaffe is a psychiatrist and pharmacologist whose work in the area of addiction spans treatment, basic and clinical research, teaching, writing,
policy, and government service. From 1971 to 1973, Dr. Jaffe served as the first Director of Special Action Office for Drug Abuse Prevention at the White
House, which formed the basis for current efforts in drug abuse research and treatment. Dr. Jaffe is currently a clinical professor of psychiatry at University
of Maryland School of Medicine and an adjunct professor at Johns Hopkins University School of Hygiene and Public Health.
The 2006 American Association for the Treatment of Opioid Dependence National Conference recognizes outstanding contributions to
methadone treatment by rewarding the Nyswander/Dole Award to the following individuals:
M. Douglas Anglin, PhD California
Dr. M. Douglas Anglin is the Associate Director of the UCLA Integrated Substance Abuse Program in the Department of Psychiatry and Biobehavioral
Sciences at the University of California. Dr. Anglin produced one of the earliest and most comprehensive bodies of work supporting the efficacy of
methadone treatment. He has been a facilitator in the development of many coalitions. His research has provided powerful documentation to use with
policy makers, funding agencies, administrators, and clinicians. He is described as a visionary, dedicated, unrepentant workaholic, brilliant, creative,
wicked wit, playful and irreverent; and a born net worker before the term was used.
Andrew Byrne, MD
National Conference Atlanta 2006
17
Australia
Dr. Andrew Byrne is an addiction medicine specialist in Redfern, Australia which is a disadvantaged inner city area. He has been a strong advocate for
methadone treatment for over eighteen years. Dr. Byrne has been a strong supporter and mentor for other doctors. He is an assiduous provider of
information about methadone treatment and other related fields to a large and growing international electronic network. He has for many years been
active in organizing continuing education for doctors and other clinicians working with drug addiction. Dr. Byrne provides both methadone treatment
and primary health care to his patients.
John Chappel, MD
Nevada
Dr. John Chappel is the Medical Director of the American Therapeutic Association Methadone Clinic in Sparks, Nevada and Professor Emeritus at the
University of Nevada Medical School. For the 35 years he has advocated for methadone treatment. He has been involved in physician training for
attending and resident physicians. In 1990 he received the ASAM Award in Physician Education and Certification. He has been involved in methadone
treatment since 1986 and has co-authored articles with Dr. Jerome Jaffe and Dr. Loretta Finnegan. Dr. Chappel is described as a person who is kind,
unassuming, and eloquent who exhibits great care when seeing patients.
Don C. DesJarlais, PhD
New York
Dr. Don DesJarlais is the Director of the Baron Edmond de Rothschild Chemical Dependency Institute at Beth Israel Medical Center, a Research Fellow
with the National Development and Research Institutes, Inc. and Professor of Epidemiology with the Department of Epidemiology and Population Health
of Albert Einstein College of Medicine. He has published over 425 articles and conducted over 1,500 presentations. He consistently helps the field
understand the psychological and social aspect of the disease. His work has demonstrated conclusively and compellingly that treatment of opiate
dependence is an absolute necessity in the face of the HIV crisis.
James S. Dorsey, MD
Maryland
Dr. James S. Dorsey is the Medical Director of the Adult Addiction Opioid Program of the Anne Arundel County Department of Health. Through his
efforts he ensured the continuation and expansion of medication assisted treatment. He continually seeks opportunities to educate; patients, politicians,
community leaders, local and national health care providers on the efficacy of medication-assisted treatment. As a researcher and clinician he has made
a significant contribution to the body of literature in the areas of pain management in methadone patients and in optimum dose levels. He is a strong
promoter of “science to service” and evidence based practices.
David A. Fiellin, MD
Connecticut
Dr. David A. Fiellin is an Associate professor of Medicine at Yale University and a Robert Wood Johnson Generalist Physician Faculty Scholar. His extensive
scholarly work is focused on the interface between primary care and substance abuse. He has published several key articles on methadone patient
treatment in medicine’s best journals. He conducts research on the transfer of treatment strategies, including opioid agonist maintenance with methadone
and buprenorphine, from specialized settings to office-based, primary care, and HIV specialty settings. He is a role model of the highest standard for
trainees in medicine including medical students, residents, fellows and junior faculty.